Absci Announces Upcoming Investor Conference Participation
![Absci Announces Upcoming Investor Conference Participation](https://investorshangout.com/images/blog/investors-hangout-newswire.jpg)
Absci to Participate in Upcoming Investor Conferences
Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will be participating in several upcoming investor conferences.
Conference Details
Absci will engage in the following events:
Morgan Stanley Annual Global Healthcare Conference
Fireside chat scheduled for Thursday, September 5 at 5:35 p.m. Eastern Time.
Citi Global TMT Conference
Fireside chat set for Friday, September 6 at 8:20 a.m. Eastern Time.
H.C. Wainwright Annual Global Investment Conference
Fireside chat planned for Tuesday, September 10 at 12:00 p.m. Eastern Time.
About Absci
Absci is a generative AI drug creation company that integrates AI with scalable wet lab technologies to expedite the development of advanced biologics. The company’s Integrated Drug Creation™ platform is designed to enhance the efficiency of bringing drugs to market by optimizing multiple critical drug characteristics simultaneously. This innovative approach enables Absci to screen billions of cells weekly, transitioning from AI-generated candidates to validated candidates in about six weeks. Absci operates from Vancouver, WA, with an AI Research Lab in New York City and an Innovation Center in Zug, Switzerland.
Contact Information
Investor Contact
Alex Khan
VP, Finance & Investor Relations
investors@absci.com
Media Contact
press@absci.com
Frequently Asked Questions
What is Absci Corporation?
Absci Corporation specializes in generative AI-driven drug creation, using innovative technologies to accelerate drug development.
What type of conferences is Absci participating in?
Absci is participating in several prominent investor conferences, including those hosted by Morgan Stanley, Citi, and H.C. Wainwright.
When are the conferences scheduled?
The conferences are scheduled for early September, with specific dates for each fireside chat mentioned in the announcement.
How does Absci's technology benefit drug development?
Absci’s technology optimizes drug characteristics simultaneously to improve the chances of success and reduce the time it takes to bring therapies to market.
How can investors contact Absci?
Investors can reach out to Absci's VP of Finance & Investor Relations, Alex Khan, via the email provided in the contact section.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/